$SY

So-Young International Inc.

3
0
0

No SEC Form 4 filings for $SY in the last 30 days.

See all $SY insider activity →
Med

So-Young International Q2 Earnings Call Highlights

So-Young International reported Q2 earnings, highlighting 52% same-store sales growth and improved unit-level profitability. Aesthetic treatment revenue grew, while other segments declined. Gross margin increased to 28.1%. The company expects Q3 aesthetic revenue of RMB352M-RMB362M, up 91.7%-97.2% YoY. Management plans to focus on clinic growth and reduce investment in loss-making businesses.

So-Young International Inc. (SY): Financial results for Q2 2026

So-Young International Inc. (SY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 So-Young Reports Unaudited Second Quarter 2026 Financial Results BEIJING, China , August 31, 2026 — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the leading aesthetic treatment platform in China connecting consumers with online services and

So-Young Reports Unaudited Second Quarter 2026 Financial Results

So-Young International Inc. (SY) reported Q2 2026 revenues of RMB505.2 million (US$74.5 million), up 33.4% YoY. Aesthetic treatment services revenue surged 129.5% YoY to RMB331.4 million (US$48.8 million). Net loss narrowed to RMB22.7 million (US$3.3 million) from RMB36.0 million YoY. Active users and treatment visits also increased significantly. The company operates 65 branded aesthetic centers, with 47 profitable and 51 generating positive cash flow. Management highlighted strong execution an

SY sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning SY (So-Young International Inc.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.

Recent SY coverage spans financial news and earnings.

What's driving SY

alphai scores every news story that mentions SY with an AI model for sentiment and relevance, and aggregates insider trades from So-Young International Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SY

Score
$SYMedAI 8/10

So-Young International Q2 Earnings Call Highlights

So-Young International reported Q2 earnings, highlighting 52% same-store sales growth and improved unit-level profitability. Aesthetic treatment revenue grew, while other segments declined. Gross margin increased to 28.1%. The company expects Q3 aesthetic revenue of RMB352M-RMB362M, up 91.7%-97.2% YoY. Management plans to focus on clinic growth and reduce investment in loss-making businesses.

$SYMed

So-Young International Inc. (SY): Financial results for Q2 2026

So-Young International Inc. (SY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 So-Young Reports Unaudited Second Quarter 2026 Financial Results BEIJING, China , August 31, 2026 — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the leading aesthetic treatment platform in China connecting consumers with online services and

$SYMed

So-Young Reports Unaudited Second Quarter 2026 Financial Results

So-Young International Inc. (SY) reported Q2 2026 revenues of RMB505.2 million (US$74.5 million), up 33.4% YoY. Aesthetic treatment services revenue surged 129.5% YoY to RMB331.4 million (US$48.8 million). Net loss narrowed to RMB22.7 million (US$3.3 million) from RMB36.0 million YoY. Active users and treatment visits also increased significantly. The company operates 65 branded aesthetic centers, with 47 profitable and 51 generating positive cash flow. Management highlighted strong execution an

So-Young Announces Appointment of Chief Financial Officer

So-Young International Inc. (Nasdaq: SY) said its board appointed Nan Shen as Chief Financial Officer effective Aug. 3, 2026. Shen, an independent director since Oct. 2023, will oversee finance, HR, legal and compliance, and will step down from board committees. She previously served as CFO at Gaotu Techedu (NYSE: GOTU).

Market Cool On So-Young International Inc.'s (NASDAQ:SY) Revenues

So-Young International Inc. (NASDAQ:SY) has a low price-to-sales (P/S) ratio of 0.6x, significantly below the industry average, despite analysts forecasting revenue growth similar to the broader Interactive Media and Services sector. The market appears unconvinced by the company's future growth prospects, questioning the revenue estimates and leading to its suppressed P/S ratio. This suggests investors anticipate revenue instability, even with expected increases.

$SYMed

So-Young Aesthetic Sales Up 426 Percent

So-Young ( NASDAQ:SY ) reported second quarter 2025 results on August 15, 2025, highlighting aesthetic treatment service revenue grew 426.1% year-over-year to RMB 144.4 million, reaching its highest segment contribution.

Related tickers